Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $74,474 - $122,261
-11,405 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $53,924 - $104,396
-6,641 Reduced 36.8%
11,405 $105,000
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $554 - $905
38 Added 0.21%
18,046 $274,000
Q3 2018

Nov 13, 2018

BUY
$21.06 - $25.65 $150,937 - $183,833
7,167 Added 66.11%
18,008 $388,000
Q2 2018

Aug 13, 2018

SELL
$16.77 - $24.71 $9,827 - $14,480
-586 Reduced 5.13%
10,841 $263,000
Q1 2018

May 14, 2018

BUY
$16.68 - $22.07 $125,617 - $166,209
7,531 Added 193.3%
11,427 $195,000
Q4 2017

Feb 09, 2018

BUY
$11.23 - $19.1 $13,824 - $23,512
1,231 Added 46.19%
3,896 $74,000
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $41,067 - $85,733
2,665
2,665 $149,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.